Pfizer said a clinical trial involving 2,260 12-to-15-year-olds showed an efficacy of 100%, and they tolerated it well.
Pfizer said a clinical trial involving 2,260 12-to-15-year-olds showed an efficacy of 100%, and they tolerated it well.
Moderna's COVID-19 vaccine was found to be effective in adolescents aged 12-17 and showed no new or major safety problems in a..
The FDA has given emergency use authorization for the Pfizer COVID-19 vaccine in teens as young as 12. The next step is expected..